The linear ubiquitin chain assembly complex regulates TRAIL‐induced gene activation and cell death

por Lafont, Elodie, Kantari‐Mimoun, Chahrazade, Draber, Peter, De Miguel, Diego, Hartwig, Torsten, Reichert, Matthias, Kupka, Sebastian, Shimizu, Yutaka, Taraborrelli, Lucia, Spit, Maureen, Sprick, Martin R, Walczak, Henning
Publicado 2017

Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexia

por Klose, Ralph, Krzywinska, Ewelina, Castells, Magali, Gotthardt, Dagmar, Putz, Eva Maria, Kantari-Mimoun, Chahrazade, Chikdene, Naima, Meinecke, Anna-Katharina, Schrödter, Katrin, Helfrich, Iris, Fandrey, Joachim, Sexl, Veronika, Stockmann, Christian
Publicado 2016

Boosting the hypoxic response in myeloid cells accelerates resolution of fibrosis and regeneration of the liver in mice

por Kantari-Mimoun, Chahrazade, Krzywinska, Ewelina, Castells, Magali, Milien, Corinne, Klose, Ralph, Meinecke, Anna-Katharina, Lemberger, Ursula, Mathivet, Thomas, Gojkovic, Milos, Schrödter, Katrin, Österreicher, Christoph, Fandrey, Joachim, Rundqvist, Helene, Stockmann, Christian
Publicado 2017

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment

por Peranzoni, Elisa, Lemoine, Jean, Vimeux, Lene, Feuillet, Vincent, Barrin, Sarah, Kantari-Mimoun, Chahrazade, Bercovici, Nadège, Guérin, Marion, Biton, Jérôme, Ouakrim, Hanane, Régnier, Fabienne, Lupo, Audrey, Alifano, Marco, Damotte, Diane, Donnadieu, Emmanuel
Publicado 2018

Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis

por Krzywinska, Ewelina, Kantari-Mimoun, Chahrazade, Kerdiles, Yann, Sobecki, Michal, Isagawa, Takayuki, Gotthardt, Dagmar, Castells, Magali, Haubold, Johannes, Millien, Corinne, Viel, Thomas, Tavitian, Bertrand, Takeda, Norihiko, Fandrey, Joachim, Vivier, Eric, Sexl, Veronika, Stockmann, Christian
Publicado 2017

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment

por Nicolas-Boluda, Alba, Vaquero, Javier, Vimeux, Lene, Guilbert, Thomas, Barrin, Sarah, Kantari-Mimoun, Chahrazade, Ponzo, Matteo, Renault, Gilles, Deptula, Piotr, Pogoda, Katarzyna, Bucki, Robert, Cascone, Ilaria, Courty, José, Fouassier, Laura, Gazeau, Florence, Donnadieu, Emmanuel
Publicado 2021

Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?

por Guedan, Sonia, Luu, Maik, Ammar, Delphine, Barbao, Paula, Bonini, Chiara, Bousso, Philippe, Buchholz, Christian J, Casucci, Monica, De Angelis, Biagio, Donnadieu, Emmanuel, Espie, David, Greco, Beatrice, Groen, Richard, Huppa, Johannes B, Kantari-Mimoun, Chahrazade, Laugel, Bruno, Mantock, Mary, Markman, Janet L, Morris, Emma, Quintarelli, Concetta, Rade, Michael, Reiche, Kristin, Rodriguez-Garcia, Alba, Rodriguez-Madoz, Juan Roberto, Ruggiero, Eliana, Themeli, Maria, Hudecek, Michael, Marchiq, Ibtissam
Publicado 2022

Time to evolve: predicting engineered T cell-associated toxicity with next-generation models

por Donnadieu, Emmanuel, Luu, Maik, Alb, Miriam, Anliker, Brigitte, Arcangeli, Silvia, Bonini, Chiara, De Angelis, Biagio, Choudhary, Rashmi, Espie, David, Galy, Anne, Holland, Cam, Ivics, Zoltán, Kantari-Mimoun, Chahrazade, Kersten, Marie Jose, Köhl, Ulrike, Kuhn, Chantal, Laugel, Bruno, Locatelli, Franco, Marchiq, Ibtissam, Markman, Janet, Moresco, Marta Angiola, Morris, Emma, Negre, Helene, Quintarelli, Concetta, Rade, Michael, Reiche, Kristin, Renner, Matthias, Ruggiero, Eliana, Sanges, Carmen, Stauss, Hans, Themeli, Maria, Van den Brulle, Jan, Hudecek, Michael, Casucci, Monica
Publicado 2022